Skip to main content
Clinical Trials/CTRI/2021/02/030932
CTRI/2021/02/030932
Recruiting
Phase 4

A Comparative evaluation of Intranasal combinations of Midazolam-Ketamine, Dexmedetomidine-Ketamine, Midazolam-Fentanyl and Dexmedetomidine-Fentanyl for Procedural Sedation and Analgesia in paediatric dental patients : Randomised Controlled Trial

Dr Agarwal Abhilasha Kishanlal0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K00-K14- Diseases of oral cavity and salivary glands
Sponsor
Dr Agarwal Abhilasha Kishanlal
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Agarwal Abhilasha Kishanlal

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients requiring any invasive dental treatment.
  • 2\)Patients who are rated as positive and negative on Frankelâ??s behaviour rating scale.
  • 3\)Patients of physical status American Society of Anesthesiologists (ASA) class I and II.
  • 4\)Signed informed consent by the parents/guardians.

Exclusion Criteria

  • 1\)Patients of physical status American Society of Anesthesiologists (ASA) Class III and IV.
  • 2\)Patients who have a history of any systemic diseases, like cardiorespiratory dysfunction and CNS dysfunction.
  • 3\)Patients who are allergic to any of the drugs considered for the present study or history of any adverse reactions to anesthetic/ sedative agents.
  • 4\)Patients with any intranasal pathology, nasal obstruction (obstructive sleep apnea) or with any congenital anomaly.

Outcomes

Primary Outcomes

Not specified

Similar Trials